期刊文献+

HPLC同时测定理气舒心片中3种活性成分 被引量:3

Simultaneous determination of three active components in tablets of Liqishuxin with HPLC
暂未订购
导出
摘要 目的利用HPLC同时测定理气舒心片中柚皮苷、橙皮苷和新橙皮苷。方法Thermo SCIENTIFIC Syncronis C18色谱柱(4.6mm×250mm,5μm);流动相为乙腈-0.1%磷酸溶液(25:75);流速1.0mL/min;柱温30℃;检测波长284nm。结果3种成分均达到基线分离,柚皮苷、橙皮苷和新橙皮苷的质量浓度与峰面积,分别在1.92~102.28μg/mL(r=0.9996),1.73~92.25μg/mL(r=0.9995),2.10~111.86μg/mL(r=0.9996)范围呈良好的线性关系;平均加样回收率分别为102.05%、99.53%、100.62%,RSD分别为0.89%、1.17%、2.02%。结论本研究建立的方法符合方法学验证要求,适用于同时测定理气舒心片中柚皮苷、橙皮苷和新橙皮苷的含量。 Objective To simultaneously determine naringin,hesperidin and neohesperidin in tablets of Liqishuxin with HPLC. Methods The determination was performed by HPLC on Thermo SCIENTIFIC Syncronis C18 column (4.6mm × 250mm,5 μm).The mobile phase consisted of acetonitrile-0.1% phosphoric acid solution(25:75) at a flow rate of 1.0 mL/min.The detection wavelength was set at 284 nm. Results Three active components were all in baseline separation.The calibration curves were linear in the range of 1.92-102.28 μg/mL for Naringin (r=0.9996),1.73- 92.25 μg/mL for Hesperidin (r=0.9995),2.10-111.86 μg/mL for Neohesperidin (r=0.9996).Average rate of recoveries respectively were 102.05%,99.53%,100.62%,and RSD respectively were 0.89%,1.17% and 2.02%. Conclusion The method is consistent with the method validation requirements,and it applies for simultaneous determination of Naringin,Hesperidin and Neohesperidin three ingredients in tablets of Liqishuxin.
出处 《中国医药科学》 2016年第15期44-46,共3页 China Medicine And Pharmacy
关键词 理气舒心片 柚皮苷 橙皮苷 新橙皮苷 HPLC Tablets of Liqishuxin Naringin Hesperidin Neohesperidin HPLC
  • 相关文献

参考文献14

二级参考文献76

共引文献178

同被引文献21

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部